Citation Impact
Citing Papers
Haemophilia B: Where are we now and what does the future hold?
2017
The C‐Type Natriuretic Peptide Receptor is the Predominant Natriuretic Peptide Receptor mRNA Expressed in Rat Hypothalamus
1995
Non‐genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report
2010
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
Basic aspects of inhibitors to factors VIII and IX and the influence of non‐genetic risk factors
2006
Intensive exposure to factor VIII is a risk factor for inhibitor development in mild hemophilia A
2003
Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study
2009 StandoutNobel
Structural basis for the anticoagulant activity of the thrombin–thrombomodulin complex
2000 NatureNobel
Aquaporins in the central nervous system
2001
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
2004 Standout
Localization of natriuretic peptide-activated guanylate cyclase mRNAs in the rat brain
1996
Natriuretic Peptides
1998 Standout
Intensive peri-operative use of factor VIII and the Arg593→Cys mutation are risk factors for inhibitor development in mild/moderate hemophilia A
2009
Survey of the year 2003 commercial optical biosensor literature
2004
A survey of the year 2002 commercial optical biosensor literature
2003
Immunogenicity of long-lasting recombinant factor VIII products
2015
A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics
2020 StandoutNobel
In non‐severe hemophilia A the risk of inhibitor after intensive factor treatment is greater in older patients: a case–control study
2010
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
2016 Standout
Surgery and inhibitor development in hemophilia A: a systematic review
2011
Autoreceptor Control of Peptide/Neurotransmitter Corelease from PDF Neurons Determines Allocation of Circadian Activity in Drosophila
2012 StandoutNobel
Survey of the year 2001 commercial optical biosensor literature
2002
Regulation of Blood Coagulation by the Protein C Anticoagulant Pathway
2005
The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells
2005 Standout
Synthetic Glycobiology: Parts, Systems, and Applications
2020
Neuropeptides phase shift the mammalian circadian pacemaker
1995
Natriuretic Peptides, Their Receptors, and Cyclic Guanosine Monophosphate-Dependent Signaling Functions
2005 Standout
Contributions of Amino Acid Side Chains to the Kinetics and Thermodynamics of the Bivalent Binding of Protein L to Ig κ Light Chain
2004 StandoutNobel
3-Dimensional structure of membrane-bound coagulation factor VIII: modeling of the factor VIII heterodimer within a 3-dimensional density map derived by electron crystallography
2002
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
Delayed onset of brain edema and mislocalization of aquaporin-4 in dystrophin-null transgenic mice
2002 StandoutNobel
Guidelines for the management of hemophilia
2012 Standout
Modulation of Procarboxypeptidase R (ProCPR) Activation by Complementary Peptides to Thrombomodulin
2003 StandoutNobel
Works of Karin Knobe being referenced
Population pharmacokinetic modeling for dose setting of nonacog beta pegol (N9‐GP), a glycoPEGylated recombinant factor IX
2012
Preprogastrin-releasing peptide messenger ribonucleic acid: Neuroanatomical localization in rat brain by in situ hybridization with synthetic oligodeoxynucleotide probes
1992
Distribution of Preproatrial Natriuretic Peptide mRNA in Rat Brain Detected by In Situ Hybridization of DNA Oligonucleotides: Enrichment in Hypothalamic and Limbic Regions
1992
The N-terminal Epidermal Growth Factor-like Domain of Coagulation Factor IX
2002
Factor VIII Inhibitors in Two Families with Mild Haemophilia A: Structural Analysis of the Mutations
2000
Inhibitors in the Swedish population with severe haemophilia A and B: a 20-year survey
2002
An Anti-EGF Monoclonal Antibody That Detects Intramolecular Communication in Factor IX
2001
Breastfeeding does not influence the development of inhibitors in haemophilia
2002
Probing the activation of protein C by the thrombin-thrombomodulin complex using structural analysis, site-directed mutagenesis, and computer modeling
1999
Enhancing the pharmacokinetic properties of recombinant factor VIII: first-in-human trial of glycoPEGylated recombinant factor VIII in patients with hemophilia A
2013
Enhanced pharmacokinetic properties of a glycoPEGylated recombinant factor IX: a first human dose trial in patients with hemophilia B
2011
Recombinant long-acting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trial
2014